GILD CapEx to Revenue

Gilead Sciences · CapEx to Revenue

GILD logo

GILD CapEx to Revenue

Current (TTM)1.16%
GILD CapEx/Revenue (23.08% → 1.16%)
High-resolution chart · PNG

GILD capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Gilead Sciences CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
1.9122%
1.8189%
2.1574%
2.6685%
2.1205%
2.6328%
3.675%
4.1759%
2.2599%
2.4613%
2.2887%
2.2378%
1.6961%
4.0919%
1.573%
0.7785%
3.2812%
2.1554%
1.8593%
3.4766%
2.364%
3.8778%
4.4487%
3.7698%
11.2637%
7.988%
7.3964%
7.2799%
10.4308%
11.0778%
22.2222%
79.5918%
104.7619%
17.8571%
23.0769%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.